Company intelligence / Profile preview

Freed

San Francisco, California, United Statesgetfreed.ai ↗

Ownership: Private
Development stage: Commercial

Overview

Freed has rapidly scaled since its launch in January 2023, now serving over 20,000 clinicians across more than 650 health organizations. The platform automates note-taking during patient visits using real-time transcription and natural language processing to generate draft medical notes tailored to each clinician’s style. Clinicians report significant time savings—up to four hours per day—and improved work-life balance due to reduced after-hours charting. The company continues to expand features beyond note-taking into broader AI assistant capabilities.

Therapeutic areas: Other
Modalities: AI-powered clinical documentation
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Freed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Freed.

Explore the full profile